Sonoma Pharmaceuticals, Inc. (SNOA) Financials

SNOA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 14.6 million 7.9 million
2023-09-30 13.6 million 8.0 million
2023-06-30 15.9 million 8.7 million
2023-03-31 16.2 million 8.3 million

SNOA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -1.1 million 140000
2023-09-30 -1.2 million 130000
2023-06-30 -232000 177000
2023-03-31 -2.6 million 100000

SNOA Net Income

No data available :(

SNOA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 2.4 million - 341000
2023-09-30 2.1 million - 350000
2023-06-30 3.5 million - 354000
2023-03-31 3.8 million - 418000

SNOA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 10.9 million
2023-09-30 5.2 million
2023-06-30 4.9 million
2023-03-31 3.4 million

SNOA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1000 601000 1.7 million -
2023-09-30 2000 536000 1.7 million -
2023-06-30 17000 325000 2.1 million -
2023-03-31 190000 201000 1.7 million 156000

SNOA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 3.1 million 1.7 million
2023-09-30 2.7 million 1.7 million
2023-06-30 3.4 million 2.2 million
2023-03-31 3.0 million 2.2 million

SNOA

Price: $0.16

52 week price:
0.12
1.52

Earnings Per Share: -0.82 USD

P/E Ratio: -0.19

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 313242

Ebitda: -12.7 million

Market Capitalization: 2.7 million

Links: